Michael Garshick, MD, examines the role of inflammation in coronary disease development, detailing how this risk factor can be detected and treated.

When should a clinician tell a patient they have a gene variant that appeared incidentally but may have ramifications for cardiovascular health?

Surgeons at NYU Langone Health successfully transplanted two genetically engineered pigs hearts into recently deceased humans in June and July.

Hello Heart, a digital therapeutics company that focuses on heart health, has raised $70 million in a Series D funding round.

While 96% of the population is located within 60 minutes of an ED with any acute stroke expertise, many smaller, critical access hospitals in rural regions still are without these lifesaving services.